Immunoglobulins unspecific

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Non-specific immunoglobulins

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Drugs containing immunoglobulins, especially IgG, as antibodies.

IndicationThis section has been translated automatically.

Primary or secondary immunoglobulin deficiency syndrome, recurrent infections in immunocompromised patients, autoimmune thrombocytopenia in AIDS patients, see also IVIG.

Dosage and method of useThis section has been translated automatically.

Intratect: Initially 0.4-0.8 g/kg bw, then 0.2-0.8 g/kg bw every 2-4 weeks to achieve an IgG blood level of at least 4-6 g/l.

Undesirable effectsThis section has been translated automatically.

Mostly harmless vasomotor disorders (headaches), fever, neutropenia, proteinuria, chills, allergic reactions up to anaphylactic shock, drop in blood pressure, dyspnoea, gastrointestinal disorders, sensation of heat, urticaria. Palmo-plantar and generalized eczematous reactions have also been described.

InteractionsThis section has been translated automatically.

The effect of live virus vaccines is reduced up to 3 months after immunoglobulin administration.

ContraindicationThis section has been translated automatically.

Hypersensitivity to immunoglobulins.

LiteratureThis section has been translated automatically.

  1. Vecchietti G et al (2006) Severe eczematous skin reaction after high-dose intravenous immunoglobulin infusion. Arch Dermatol 142: 213-217

Authors

Last updated on: 29.10.2020